Protecting Research Data and Intellectual Property
We help strengthen access controls, monitoring, and recovery planning around laboratory environments, research repositories, and proprietary data.
Biotech firms, pharmaceutical companies, clinical research organizations, and medical device manufacturers operate at the intersection of cutting-edge science and strict regulatory expectations. ACS helps strengthen safeguards around research environments, intellectual property, and the systems that keep scientific work moving forward.

Built around lab systems, clinical-trial data, IP protection, 21 CFR Part 11 readiness, and research continuity.
ACS helps life sciences teams protect research operations, regulated workflows, collaboration platforms, and sensitive data.
We help strengthen access controls, monitoring, and recovery planning around laboratory environments, research repositories, and proprietary data.
ACS helps implement controls that support 21 CFR Part 11 readiness and inspection-response preparation without disrupting research workflows.
From startup labs to clinical-stage operations, we scale your IT and security infrastructure alongside your growth.
Life sciences companies hold some of the most valuable intellectual property in the world. Years of clinical research, proprietary formulations, and unreleased trial data represent enormous competitive and financial value. Nation-state actors and organized criminal groups actively target this sector for data theft, ransomware, and industrial espionage.
Pharmaceutical and biotech IP is a high-value target for criminal and nation-state cyber activity
Clinical-trial data exposure can disrupt research timelines, sponsor reporting, and regulatory response needs
21 CFR Part 11 expectations raise the importance of documented audit trails and access controls for electronic records
Medical-device and connected research teams face growing expectations for documented controls, secure access, and supplier-risk visibility
ACS connects managed IT, cybersecurity, continuity, advisory, and assessment services around the priorities that matter most for this industry.
Controlled access, network segmentation, and monitoring for lab systems, sequencing platforms, and connected research equipment.
Advisory support for electronic-signature controls, audit-trail documentation, and validation-support documentation in FDA-regulated environments.
Access, endpoint, email, and recovery controls for trial records, patient data, and sponsor reporting systems throughout the research lifecycle.
Risk assessment and control-prioritization support for connected research, lab, and product-supporting environments.
Layered controls to reduce unauthorized-access risk around formulations, research data, and proprietary processes.
Ongoing assessments, evidence management, and gap prioritization so your organization is better prepared for regulatory and sponsor review.
ACS helps life sciences teams align IT, cybersecurity, advisory priorities, and recovery planning around research data, regulated workflows, vendor ecosystems, and systems that support discovery.
Security guidance for sensitive research, intellectual property, collaboration spaces, and regulated workflows.
Protection for accounts, devices, email, and access paths used by research, clinical, and business teams.
Backup and recovery planning for systems supporting research operations, documentation, and collaboration.
Strategic IT and cyber guidance for teams navigating growth, governance, vendors, and sensitive data handling.
We’ll help identify the most important technology and cyber-risk priorities for your organization, then map practical next steps.